Published in Clin Drug Investig on December 01, 2011
Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers. Drug Des Devel Ther (2014) 0.78
Current management of functional dyspepsia: impact of Rome III subdivision. Ann Gastroenterol (2012) 0.76
Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia. World J Gastrointest Pharmacol Ther (2017) 0.75
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82
Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut (2012) 2.36
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology (2009) 1.78
MR colonography with barium-based fecal tagging: initial clinical experience. Radiology (2002) 1.67
Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology (2008) 1.63
G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia. Brain Behav Immun (2008) 1.49
Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. AJR Am J Roentgenol (2003) 1.46
Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn? J Gastrointest Surg (2008) 1.44
On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study. J Clin Gastroenterol (2007) 1.39
Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY. J Clin Biochem Nutr (2007) 1.36
Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr (2013) 1.29
Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol (2008) 1.17
Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol (2004) 1.13
MR colonography in patients with incomplete conventional colonoscopy. Radiology (2004) 1.09
Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain (2006) 1.09
Circulating levels of periostin may help identify patients with more aggressive colorectal cancer. Int J Oncol (2009) 1.08
Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. Am J Physiol Gastrointest Liver Physiol (2007) 1.07
Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol (2010) 1.05
Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol (2004) 0.99
Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disorders. Clin Gastroenterol Hepatol (2009) 0.98
Mechanisms of disease: genetics of functional gastrointestinal disorders--searching the genes that matter. Nat Clin Pract Gastroenterol Hepatol (2007) 0.96
Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol (2011) 0.95
Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol (2006) 0.94
Study on the function of pharynx upper esophageal sphincter in globus hystericus. World J Gastroenterol (2002) 0.93
Effect of emodin and sandostatin on metabolism of eicosanoids in acute necrotizing pancreatitis. World J Gastroenterol (2000) 0.92
Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. J Gastroenterol Hepatol (2007) 0.88
Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer. Oncol Rep (2011) 0.88
Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful friendship in research and practice? Am J Gastroenterol (2006) 0.88
Voltage-gated potassium channels in IB4-positive colonic sensory neurons mediate visceral hypersensitivity in the rat. Am J Gastroenterol (2009) 0.88
BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK. Front Biosci (Landmark Ed) (2012) 0.87
Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice. World J Gastroenterol (2002) 0.86
Involvement of apoptosis of alveolar epithelial cells in acute pancreatitis-associated lung injury. World J Gastroenterol (2000) 0.85
Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol (2007) 0.84
High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells. World J Gastroenterol (2012) 0.84
Ablation of connexin43 in smooth muscle cells of the mouse intestine: functional insights into physiology and morphology. Cell Tissue Res (2006) 0.84
Papillomatosis confined to the distal biliary tract--a rare cause of obstructive jaundice: report of a case. Surg Today (2003) 0.83
Real-time high-resolution MRI for the assessment of gastric motility: pre- and postpharmacological stimuli. J Magn Reson Imaging (2004) 0.83
Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain (2006) 0.83
Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol (2015) 0.83
Effect of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension. Eur J Gastroenterol Hepatol (2002) 0.83
A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation. World J Gastroenterol (2007) 0.82
GERD evaluation: time for a new paradigm? J Clin Gastroenterol (2007) 0.81
MicroRNA155 is induced in activated CD4(+) T cells of TNBS-induced colitis in mice. World J Gastroenterol (2010) 0.81
Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines. Digestion (2009) 0.81
An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation. Inflamm Bowel Dis (2011) 0.81
Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study. BMC Health Serv Res (2009) 0.80
Non-erosive reflux disease--defining the entity and delineating the management. Digestion (2008) 0.80
Functional dyspepsia. Curr Opin Gastroenterol (2016) 0.80
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome. J Gastroenterol (2013) 0.79
The origins of vacularization in tumors. Front Biosci (Landmark Ed) (2012) 0.79
GERD 2003 -- a consensus on the way ahead. Digestion (2003) 0.79
Endoscopic features predictive of gastric cancer in superficial lesions with biopsy-proven high grade intraepithelial neoplasia. World J Gastroenterol (2009) 0.77
Cost and time savings from a rapid access model of care using transient elastography to screen and triage patients with chronic Hepatitis C infection. J Med Econ (2013) 0.77
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study. Medicine (Baltimore) (2016) 0.77
A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model. Scand J Gastroenterol (2006) 0.77
Serum ferritin and survival of renal transplant recipients: a prospective 10-year cohort study. Transpl Int (2003) 0.76
IBD: Stress causes flares of IBD--how much evidence is enough? Nat Rev Gastroenterol Hepatol (2011) 0.76
Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model. Scand J Gastroenterol (2009) 0.76
Are all symptoms in patients in IBD due to occult inflammation? Am J Gastroenterol (2010) 0.75
(Post) inflammatory visceral hyperalgesia: don't we believe what we don't see? Gastroenterology (2002) 0.75
Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia. Neurosci Bull (2010) 0.75
Clinical study on the influence of a fixed-dose combination of famotidine with calcium carbonate and magnesium hydroxide on the bioavailability of famotidine. Arzneimittelforschung (2008) 0.75
Intraoperative cholangioscopy in the management of biliary adenomas. J Surg Oncol (2004) 0.75
Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: a pilot randomized controlled trial. Eur J Gastroenterol Hepatol (2009) 0.75
Colonic transit studies with 99mTc-rhenium sulfide colloid in live rats. A preliminary study. Hell J Nucl Med (2008) 0.75